Anti-tumour necrosis factor treatment and pregnancy: the way is open

被引：0
|
作者：
Boulman, N. [1 ]
Rimar, D. [1 ]
Rozenbaum, M. [1 ]
Slobodin, G. [2 ]
Younis, S. [1 ]
Rosner, I. [1 ]
机构：
[1] Bnai Zion Med Ctr, Dept Rheumatol, IL-31048 Haifa, Israel
[2] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2012年 / 30卷 / 03期
关键词：
THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：453 / 453
页数：1
相关论文
共 50 条
  • [41] ANTI-TUMOUR NECROSIS FACTOR COST-SAVING AUDIT
    Suresh, Resmy
    Kiely, Patrick
    RHEUMATOLOGY, 2017, 56 : 194 - 194
  • [42] Retention on anti-tumour necrosis factor therapy: the Waikato experience
    Ip, Ken
    Hartley, Lorraine
    Solanki, Kamal
    White, Douglas
    NEW ZEALAND MEDICAL JOURNAL, 2015, 128 (1415) : 34 - 40
  • [43] Anti-Tumour Necrosis Factor Therapy for Ulcerative ColitisEvidence to Date
    Chandrashekhar Thukral
    Adam Cheifetz
    Mark A. Peppercorn
    Drugs, 2006, 66 : 2059 - 2065
  • [44] The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis
    Camussi, G
    Lupia, E
    DRUGS, 1998, 55 (05) : 613 - 620
  • [45] Anti-tumour necrosis factor-α treatment for perianal Crohn's disease in Australia
    Burger, Daniel C.
    Lawrance, Ian C.
    Bampton, Peter A.
    Prosser, Ruth
    Croft, Anthony
    Gilshenan, Kristen
    Radford-Smith, Graham L.
    Florin, Timothy H.
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (07) : 375 - 377
  • [46] Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis
    Barber, J
    Sheeran, T
    Mulherin, D
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (05) : 490 - 491
  • [47] Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients
    Mohabbat, A. B.
    Sandborn, W. J.
    Loftus, E. V., Jr.
    Wiesner, R. H.
    Bruining, D. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (06) : 569 - 574
  • [48] Identification of single nucleotide polymorphisms associated with response to anti-tumour necrosis factor treatment
    Gibbons, Laura J.
    Potter, Catherine
    Ke, Xiayi
    Hyrich, Kimme
    Morgan, Ann W.
    Wilson, Anthony G.
    Isaacs, John D.
    Barton, Anne
    RHEUMATOLOGY, 2008, 47 : II12 - II12
  • [49] Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease
    Triolo, G
    Vadalà, M
    Accardo-Palumbo, A
    Ferrante, A
    Ciccia, F
    Giardina, E
    Citarrella, P
    Lodato, G
    Licata, G
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (06) : 560 - 561
  • [50] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    RHEUMATOLOGY, 2016, 55 : 105 - 105
12345